High-Dose Influenza Vaccine Linked to Lower Risk of Myocarditis, Pericarditis in Older Adults
New findings suggest high-dose influenza vaccines offer better protection against the flu and reduce cardiac complications in older adults.
Expert Q&A: How Orforglipron Could Transform Obesity Treatment
Katherine Saunders, MD, weighs in on orforglipron’s potential to expand obesity treatment options, improve adherence with a simple oral regimen,…
The Evolving Role of Retail Pharmacies in Expanding Buprenorphine Access
Pharmacies increasingly dispense buprenorphine, enhancing access to opioid addiction treatment while embracing AI and telepharmacy innovations for better care.
RSV Vaccination Could Protect Older Adults From Hospitalization Across Multiple RSV Seasons
A single dose of an RSV vaccine significantly reduces hospitalization risk for older adults, offering protection for 2 seasons against…
GLP-1s Reduce Risk of Hospitalization, Mortality by Over 40% in Patients with HFpEF
GLP-1 medications like semaglutide and tirzepatide significantly lower heart failure hospitalization risks, expanding treatment options for obesity-related conditions.
Designing for Safety: The Pharma Industry’s Role in Preventing Medication Errors
Pharmaceutical companies must consider formulation, packaging, and labeling from the start to minimize errors and protect patients
Azelastine Nasal Spray Reduces Risk of SARS-CoV-2 Infection
Azelastine, commonly used in nasal sprays to combat allergies, was found to reduce the incidence of SARS-CoV-2 among healthy controls…
Zongertinib Receives Breakthrough Therapy Designation for Patients With HER2 Non-Small Cell Lung Cancer
Zongertinib promises significant advancements in patient care.
Potential for Precision: Exploring Targeted Therapies in mCRC Care
Panelists discuss how the importance of having pharmacists embedded in oncology clinics has transformed metastatic colorectal cancer care by enabling…
A Pharmacist’s View of Emerging CML Treatment
A panelist discusses how emerging chronic myeloid leukemia treatment advancements, including the addition of asciminib as a frontline tyrosine kinase…